Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LogicMark, Inc. | President and CEO, Director | Common Stock | 123K | $11.2K | $0.09 | Jan 2, 2025 | Direct |
LogicMark, Inc. | President and CEO, Director | Series A Common Stock Purchase Warrant | 5.71K | $714 | $0.13 | Nov 26, 2024 | Direct |
LogicMark, Inc. | President and CEO, Director | Series B Common Stock Purchase Warrant | 5.71K | $714 | $0.13 | Nov 26, 2024 | Direct |
Chromocell Therapeutics Corp | Director | Stock Option | 105K | Jun 14, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LGMK | LogicMark, Inc. | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | President and CEO, Director |
LGMK | LogicMark, Inc. | Nov 26, 2024 | 2 | $1.21K | 4 | Nov 29, 2024 | President and CEO, Director |
LGMK | LogicMark, Inc. | Aug 5, 2024 | 3 | $10.2K | 4/A | Oct 3, 2024 | Director |
CHRO | Chromocell Therapeutics Corp | Jun 14, 2024 | 1 | $0 | 4 | Jun 18, 2024 | Director |
LGMK | LogicMark, Inc. | Apr 3, 2024 | 1 | $0 | 4 | Apr 5, 2024 | President and CEO, Director |
CHRO | Chromocell Therapeutics Corp | Feb 15, 2024 | 0 | $0 | 3 | Feb 15, 2024 | Director |
LGMK | LogicMark, Inc. | Aug 7, 2023 | 1 | $0 | 4 | Aug 9, 2023 | Chief Executive Officer, Director |
LGMK | Nxt-ID, Inc. | Jan 3, 2022 | 1 | $0 | 4/A | Feb 18, 2022 | Chief Executive Officer, Director |
LGMK | Nxt-ID, Inc. | Jun 14, 2021 | 1 | $0 | 4 | Jun 23, 2021 | Chief Executive Officer, Director |
LGMK | Nxt-ID, Inc. | Jun 14, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Chief Executive Officer, Director |